Chronic Kidney Disease Trial, Recruiting NCT06521801 Sponsor: Queen Mary University of London Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06521801
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 16 years or older, both male and female, may be included.
  • People who have been seen by the Kidney (Nephrology) team at the Royal Liverpool Hospital for a kidney-related condition may be included.
  • Adults who are considered vulnerable or unable to give consent may also be included if they have been referred to the Kidney team.

Who may not be able to join:

  • People under the age of 16 will not be included in this study.
  • Children are excluded from this study entirely.

Important note on consent: This study uses an existing patient database, so individual informed consent is not collected — patients seen by the Kidney team are automatically included in the database used for this research. If this raises any questions or concerns, confirm the details directly with the trial site.


Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02073777000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Queen Mary University of London
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
1 June 2030

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Mortality; Re-admission rates; Major Adverse Cardiac Events; Major Adverse Kidney Events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov